Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVelocity Comp Regulatory News (VEL)

Share Price Information for Velocity Comp (VEL)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
15.00
Ask:
16.00
Spread: 1.00 (6.667%)
Market Cap: £8.47m
VEL Live PriceLast checked at - London Stock Exchange

Intraday Velocity Comp Share Chart

NASDAQ IPO pricing

28 Jan 2011 07:00

RNS Number : 2495A
Velti PLC
28 January 2011
 



 

January 28, 2011

 

Velti Announces Pricing of Initial Public Offering

Dublin, Ireland and San Francisco, CA - Velti plc ('Velti' or 'the Company'), a leading mobile marketing and advertising technology provider for brands, advertising agencies, mobile operators and media, today announced that it has priced its initial public offering in the United States of 12,518,008 ordinary shares at a price to the public of $12.00 per share. Of the ordinary shares sold in the offering, Velti is offering 11,092,300 shares and selling shareholders are offering 1,425,708 shares. In addition, Velti and the selling shareholders have granted the underwriters a 30-day option to purchase up to an additional 1,877,700 ordinary shares to cover over-allotments, if any. The shares will begin trading on the NASDAQ Global Select Market on January 28, 2011 under the symbol "VELT."

Jefferies & Company, Inc. are acting as the sole book-running lead manager for the offering. Needham & Company LLC, RBC Capital Markets Corp., Canaccord Genuity Inc., and ThinkEquity LLC are acting as co-managers.

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on January 27, 2011. This offering is being made solely by means of a written prospectus forming part of the effective registration statement. Copies of the final prospectus relating to the offering may be obtained, when available, from: Jefferies & Company, Inc., Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, telephone: (877) 547-6340, email: Prospectus_Department@Jefferies.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

END

For further information, please contact:

 

Bankside Consultants

Simon Bloomfield simon.bloomfield@bankside.com

+44 (0) 207 367 8861

 

The Blueshirt Group

Mike Bishop

mike@blueshirtgroup.com

+1 (415) 217 4968

 

RBC Capital Markets

(NOMAD and Broker)

Joshua Critchley

Matthew Coakes

Daniel Conti

+44 (0) 207 653 4000

 

Velti plc

Dakota Sullivan

VP, Global Marketing

dsullivan@velti.com

+1 (415) 315 3436

 

Jefferies & Company, Inc.

Attention: Equity Syndicate Prospectus Department

520 Madison Avenue

New York, NY 10022

(877) 547-6340

Prospectus_Department@Jefferies.com

 

 

About Velti

Velti is a provider of mobile marketing and advertising solutions that enable brands, advertising agencies, mobile operators and media to implement campaigns by communicating with and engaging consumers via their mobile devices. Velti is a publicly-held corporation based in Jersey and trades on NASDAQ Global Select Market under the symbol VELT and on the London Stock Exchange's AIM under the symbol VEL.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZMGZMVRVGMZG
Date   Source Headline
20th Dec 20222:00 pmRNSPrice Monitoring Extension
20th Dec 202211:05 amRNSSecond Price Monitoring Extn
20th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20229:05 amRNSSecond Price Monitoring Extn
20th Dec 20229:00 amRNSPrice Monitoring Extension
20th Dec 20227:01 amRNSTrading Update & Notice of Results
20th Dec 20227:00 amRNSUS $100M GKN Agreement
15th Nov 20223:09 pmRNSHolding(s) in Company
9th Nov 20227:00 amRNSDirectorate Change
11th Oct 20227:00 amRNSDirectorate Change
7th Oct 20227:00 amRNSExercise of Share Options and Issue of Equity
29th Jun 20227:00 amRNSUnaudited Half Year Results
23rd Jun 20227:00 amRNSInvestor Presentation
9th Jun 20223:31 pmRNSDirectorate Change
8th Jun 20227:00 amRNSDirectorate Change
24th May 20227:00 amRNSTrading Update and Notice of Results
7th Apr 20227:00 amRNSDirector/PDMR Shareholding
29th Mar 20225:30 pmRNSExercise of Share Options and Issue of Equity
29th Mar 20223:52 pmRNSDirectorate Change and Grant of Options
17th Mar 202210:57 amRNSGrant of Share Options
1st Mar 20223:45 pmRNSResults of Annual General Meeting
26th Jan 20227:00 amRNSPublication of Annual Report and Notice of AGM
24th Jan 20227:00 amRNSFinal Results
17th Jan 20227:00 amRNSInvestor Presentation
1st Dec 20217:00 amRNSTrading Update & Notice of Results
28th Sep 202112:14 pmRNSHolding(s) in Company
15th Sep 20212:25 pmRNSDirectorate Change
30th Jul 202110:02 amRNSHolding(s) in Company
1st Jul 20212:28 pmRNSHolding(s) in Company
30th Jun 20217:00 amRNSHalf-year Report
17th Jun 20217:00 amRNSInvestor Presentation
28th May 20214:30 pmRNSTotal Voting Rights
25th May 20218:30 amRNSIssue of Equity
24th May 20217:00 amRNSTrading Statement
14th May 20212:05 pmRNSSecond Price Monitoring Extn
14th May 20212:00 pmRNSPrice Monitoring Extension
14th May 20217:00 amRNSContract
1st Apr 202110:15 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSThree Year Contract Extension
23rd Feb 20214:14 pmRNSResult of AGM
10th Feb 20215:56 pmRNSDirector/PDMR Shareholding
9th Feb 20219:00 amRNSIssue of Equity
2nd Feb 20212:30 pmRNSContract
26th Jan 20217:00 amRNSFinal Results
25th Jan 202111:45 amRNSNotice of Results
15th Jan 20214:41 pmRNSSecond Price Monitoring Extn
15th Jan 20214:36 pmRNSPrice Monitoring Extension
30th Nov 20202:05 pmRNSSecond Price Monitoring Extn
30th Nov 20202:00 pmRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.